Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2010
10/06/2010EP2236137A1 Pharmaceutical composition for treatment of fatty liver diseases
10/06/2010EP2236136A1 Angiogenesis inhibitor containing amine derivate as active ingredient
10/06/2010EP2236135A1 Stable pharmaceutical composition
10/06/2010EP2236134A1 Combinations of DMXAA and other anti-cancer agents
10/06/2010EP2236133A1 Pharmaceutical composition comprising fentanyl for the treatment of acute or breakthrough pain by sublingual administration
10/06/2010EP2236132A1 Pharmaceutical composition for the treatment of insomnia by sublingual administration
10/06/2010EP2236131A2 Compositions for manipulating the lifespan and stress response of cells and organisms
10/06/2010EP2236129A2 Liposomal ALA Pharmaceutical and Cosmeceutical Compositions and Methods of Treatment
10/06/2010EP2236126A1 Hair and/or Scalp Care Compositions Incorporating Isophaseollin
10/06/2010EP2235178A2 Compositions and methods for modulating vascular endothelial growth factor c (vegf-c) expression
10/06/2010EP2235175A1 Polypeptide-nucleic acid conjugates and uses thereof
10/06/2010EP2235037A1 Steroid derivatives acting as glucocorticosteroid receptor agonists
10/06/2010EP2235036A1 Saccharide lupane derivatives, their use and pharmaceutical compositions containing these derivatives
10/06/2010EP2235035A2 C-21 thioethers as glucocorticoid receptor agonists
10/06/2010EP2235034A2 Immunomodulatory agents and methods of use
10/06/2010EP2235032A2 Chemical-catalytic method for the peracylation of oleuropein and its products of hydrolysis
10/06/2010EP2235031A2 Synthesis of novel neamine derivatives and use thereof as antibacterial agents
10/06/2010EP2235030A1 Compound of the disaccharide type composition comprising and method for producing such a compound
10/06/2010EP2235022A1 Dimeric derivatives of artemisinin and application in anticancer therapy
10/06/2010EP2235020A1 Pyrazolo [1,5-a] pyrimidine compounds
10/06/2010EP2235018A1 Pharmaceutically acceptable salts of methyl (3-{ ýý3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl¨(3- morpholin-4-ylpropyl) amino¨methyl }phenyl) acetate and their use in therapy
10/06/2010EP2235017A1 Spiroindolinone derivatives as anticancer agents
10/06/2010EP2235016A1 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof
10/06/2010EP2235015A2 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof
10/06/2010EP2235014A2 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
10/06/2010EP2235013A1 Substituted tetrahydroimidazopyridine compounds and the use thereof in pharmaceuticals
10/06/2010EP2235012A2 4-aminopyrimidine derivatives as histamine h4 receptor antagosnists
10/06/2010EP2235011A1 Substituted pyrrolo[2, 3-b]and pyrazolo[3, 4-b]pyridines for use as adenosine receptor ligands
10/06/2010EP2235010A1 Bicyclic derivatives for use in the treatment of androgen receptor associated conditions
10/06/2010EP2235009A1 Synthesis of paliperidone
10/06/2010EP2235008A2 Amide compounds as boosters of antivirals
10/06/2010EP2235007A1 6h-dibenz0 [b, e] oxepine derived nonsteroidal mineralocorticoid receptor antagonists
10/06/2010EP2235006A1 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands
10/06/2010EP2235005A2 Azolylmethyloxiranes, use thereof and agents containing the same
10/06/2010EP2235004A1 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolmone derivatives as kinase inhibitors useful in the treatment of cancer
10/06/2010EP2235003A1 Derivatives of indole 2-carboxamides and azaindole 2-carboxamides substituted by a silanyle group, preparation thereof and therapeutic use thereof
10/06/2010EP2235002A1 4-pyridinone compounds and their use for cancer
10/06/2010EP2235001A1 4-pyridinone compounds and their use for cancer
10/06/2010EP2234999A1 Heteroaryl derivatives as orexin receptor antagonists
10/06/2010EP2234998A2 Specific inhibitors of pteridine reductase with antiparasitic action
10/06/2010EP2234995A1 Leukotriene b4 inhibitors
10/06/2010EP2234992A2 Piperazine derivatives and their use as leptin receptor modulators
10/06/2010EP2234990A1 Bifeprunox derivatives
10/06/2010EP2234989A1 Tetrazole-substituted arylamide derivatives and their use as p2x3 and/or p2x2/3 purinergic receptor antagonists
10/06/2010EP2234985A1 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof
10/06/2010EP2234984A1 Fluoroalkyl substituted benzimidazole cannabinoid agonists
10/06/2010EP2234983A1 4-imidazolidinones as kv1.5 potassium channel inhibitors
10/06/2010EP2234982A1 Substituted hydantoins as mek kinase inhibitors
10/06/2010EP2234981A1 Novel imidazole-substituted arylamides
10/06/2010EP2234980A1 Fused cynopryridines and the use thereof
10/06/2010EP2234978A1 Carbamoyl compounds as dgat1 inhibitors 190
10/06/2010EP2234977A1 Viral polymerase inhibitors
10/06/2010EP2234976A1 Novel pyrazole-substituted arylamides
10/06/2010EP2234973A1 Anthelmintic agents and their use
10/06/2010EP2234972A1 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands
10/06/2010EP2234971A1 Process and intermediates for the synthesis of heterocyclic substituted piperazines with cxcr3 antagonist activity
10/06/2010EP2234968A1 (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
10/06/2010EP2234967A1 Compounds from mycelium of antrodia cinnamomea and use thereof
10/06/2010EP2234966A2 Azetidine derivatives, their preparation and their application in therapy
10/06/2010EP2234965A1 Creatinol-fatty acid esters
10/06/2010EP2234963A1 Controlled release formulations of levodopa and uses thereof
10/06/2010EP2234954A1 Tetrasubstituted benzenes
10/06/2010EP2234669A1 Design and selection of medicaments that modulate the function and activity of interleukin 13
10/06/2010EP2234664A2 Methods for incorporating a drug into an elastomeric medical device related applications
10/06/2010EP2234643A2 Composition for treatment of tuberculosis
10/06/2010EP2234626A1 Method and means for producing bronchorelaxation
10/06/2010EP2234625A2 Compositions and methods for treating and preventing skeletal muscle deficiencies
10/06/2010EP2234622A2 Methods for enhancing muscle performance and tone
10/06/2010EP2234621A1 Compositions and methods for treating diseases of the nail
10/06/2010EP2234619A2 Methods and compositions for treating intervertebral disc herniations
10/06/2010EP2234618A1 Benzopyrans and analogs as rho kinase inhibitors
10/06/2010EP2234617A1 Dosing regimen associated with long acting injectable paliperidone esters
10/06/2010EP2234616A1 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/06/2010EP2234615A1 4-imidazolidinones as kv1.5 potassium channel inhibitors
10/06/2010EP2234614A2 Pharmaceutical composition
10/06/2010EP2234613A1 P-menthawe-3-carboxylic acid esters to treat airways diseases
10/06/2010EP2234610A2 Use of aminopeptidase inhibitors or azaindole compounds for preventing or treating cancerous metastases from epithelial origin
10/06/2010EP2234609A1 Treatment of heart disease using -blockers
10/06/2010EP2234608A2 Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
10/06/2010EP2234607A1 A slow-release formulation based on an association of glycogen and alginate
10/06/2010EP2234604A2 Pharmaceutical compositions
10/06/2010EP2234602A1 Active pharmaceutical ingredient on a solid support, amorphous and with an improved solubility
10/06/2010EP2234599A1 Implantable devices for promoting reendothelialization and methods of use thereof
10/06/2010EP2234597A1 Enhancing photostabilization of oxymetazoline
10/06/2010EP2234595A2 Organic compounds
10/06/2010EP2234505A1 Use of sphingomyelin and non-digestible carbohydrates for improving intestinal microbiota
10/06/2010EP2234498A1 Composition of aqueous buffer solution for the treatment of cellular environment and ion channels and methods for using same
10/06/2010EP2234491A1 Dosage regimens and pharmaceutical compositions and packages for emergency contraception
10/06/2010EP2234490A2 Substituted 4-{3-ý6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9h-purin-2-yl¨-prop-2-ynyl}-piperidine-1-carboxylic acid esters as a2ar agonists
10/06/2010EP2234486A1 Benzimidazoles and analogs as rho kinase inhibitors
10/06/2010EP2234485A1 Stable laquinimod preparations
10/06/2010EP2234483A2 Methods and compositions for diagnosing complications of pregnancy
10/06/2010EP2234478A1 Rasagiline formulations, their preparation and use
10/06/2010EP2131862B1 Fuid photosensitizer for therapeutic photodynamic skin treatment and its use in non therapeutic photodynamic skin treatments
10/06/2010EP1987038B1 Hcv ns5b inhibitors
10/06/2010EP1910325B1 New pharmaceutical compounds
10/06/2010EP1865941B1 Oils of capsaicinoids and methods of making and using the same
10/06/2010EP1807048B1 Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation
10/06/2010EP1776349B1 2-amino-quinazoline derivatives useful as inhibitors of beta-secretase (bace)
10/06/2010EP1755388B1 Mixed co-crystals and pharmaceutical compositions comprising the same
1 ... 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 ... 7860